Registered Uganda · NDA

N. MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TT + N. MENINGITIDIS GROUP C POLYSACCHARIDE CONJUGATED TO CRM197 + N. MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO CRM197 + N. MENINGITIDIS GROUP W POLYSACCHARIDE CONJUGATED TO CRM197 + N. MENINGITIDIS GROUP X POLYSACCHARIDE CONJUGATED TO TT

NDA/MAL/HDP/12126 PARENTERAL ORDINARY DRY VIALS 5 µG + 5 µG + 5 µG + 5 µG + 5 µG

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

NDA/MAL/HDP/12126

Registration date

05/09/2025

Expiry date

Status

Registered

Active ingredient

Dosage form

PARENTERAL ORDINARY DRY VIALS

Strength

5 µG + 5 µG + 5 µG + 5 µG + 5 µG

Pack size

I. 1*50*5DOSE VIAL + 1*5*10*2.5ML AMPOULE SODIUM CHLORIDEII. 1*50*1DOSE VIAL + 1*5*10*0.5ML AMPOULE SODIUM CHLORIDE

Therapeutic class

Manufacturer / MAH

Serum Institute Of Indai Pvt. Ltd. 212/2 Hadapsar Pune 411028 India

Applicant / LTR

SERUM INSTITUTE OF INDIA PVT LTD (SIIPL)

Country of origin

INDIA

Manufacturer location

Serum Institute Of India, 212/2, off Soli Poonawalla Road, Parijat Colony, Sadhana Society, Hadapsar, Pune, Maharashtra 411028, India

Source: National Drug Authority · fetched 2026-04-21 17:37:05 · updated 2026-09-12 04:00:20

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.